Drug factory · FDA FEI 3005604782

Bracco Imaging Spa

VIA RIBES 5, Colleretto Giacosa, Italy

Italy: 1

Problems found, fixed voluntarily at FDA's last inspection, Nov 27, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

2 drug inspections on record since 2023: 0 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
Distearoylphosphatidylcholine, Dl- and Sodium 1,2-Dipalmitoyl-Sn-Glycero-3-Phospho-(1'-Rac-Glycerol) and Sulfur HexafluorideMakes it and tests it Bracco Diagnostics Inc. 0270-7097, 0270-7099
GadoteridolTests it Bracco Diagnostics Inc. 0270-1111

FDA inspection history

EndedResultProgramProblems noted
Nov 27, 2025Problems found, fixed voluntarilyDrug Quality Assurance—
Mar 24, 2023Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; manufacture.